FIELD: medicine; veterinary.
SUBSTANCE: method includes administering an effective amount of garcinol. This enables to prevent rise in levels of TGF-β, ICAM-1,C-reactive protein, T-cell immune response, bilirubin, serum enzymes, TNF-α at lower concentrations compared to other hepatoprotectors.
EFFECT: group can be used for protection of hepatocytes of mammals during damage thereof.
22 cl, 13 dwg, 7 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CALEBIN A FOR HEPATIC STEATOSIS | 2015 |
|
RU2643297C2 |
| CALEBIN-A POTENTIAL AS ANTI-OBESITY AGENT | 2012 |
|
RU2543334C1 |
| "CORSILIN" AS HEPATOPROTECTIVE PRODUCT | 2002 |
|
RU2205637C1 |
| METHOD OF TREATING LIVER DISEASES OF VARIOUS GENESES | 2009 |
|
RU2400233C1 |
| COMPOSITIONS, METHODS AND MEDICAL COMPOSITIONS FOR TREATMENT AND MAINTENANCE OF LIVER HEALTH | 2016 |
|
RU2755475C2 |
| HEPATOPROTECTOR PREPARATION FOR PROPHYLAXIS AND CORRECTION OF TOXIC HEPATIC LESIONS | 2001 |
|
RU2189817C1 |
| COMPOSITIONS, METHODS AND MEDICAL COMPOSITIONS FOR TREATMENT AND MAINTENANCE OF LIVER HEALTH | 2016 |
|
RU2755478C2 |
| METHOD FOR PRODUCING A MEDICINAL PRODUCT EXHIBITING HEPATOPROTECTIVE AND ANTIHEPATOTOXIC ACTIONS | 2020 |
|
RU2771028C1 |
| METHOD OF OBTAINING OF HEPATOPROTECTIVE AGENT FROM MARIGOLD FLOWERS (TAGETES PATULA L) | 2007 |
|
RU2336893C1 |
| AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
